CUNY Graduate Center has developed an innovative model of artificial intelligence

October 31, 2022

The world of science remains conservative and focuses on comprehensive usage of AI for the benefit of our health. A research team at the CUNY Graduate Center has developed a novel AI model to improve the accuracy and reduce the time and cost of the drug development process. The model, called CODE-AE, screens novel drug compounds to accurately predict efficacy in humans.
Tests, undergone on over 9,000 patients, show its high level of prediction of personalized drugs that could better treat conditions of individual patients.

CUNY Graduate Center has developed an innovative model of artificial intelligence

Elon Musk called synthetic data the next stage in the development of AI

Kazakhstan entered the top 25 countries in terms of e-government development and the top 10 in terms of online services index

OpenAI Co-Founder: AI Training Data Is Running Out

Kazakhstan and China have begun exchanging permits electronically

Alibaba Unveils 'Thinking' AI

Live Broadcast of the "Project of the Year" Award Ceremony